A 0 1 0 1 O
personal 2 10 2 10 O
history 11 18 11 18 O
of 19 21 19 21 O
breast 22 28 22 28 B-cancer
, 28 29 28 29 O
ovarian 30 37 30 37 B-cancer
, 37 38 37 38 O
or 39 41 39 41 O
endometrial 42 53 42 53 B-cancer
cancer 54 60 54 60 I-cancer

Abnormal 0 8 61 69 B-chronic_disease
thyroid 9 16 70 77 I-chronic_disease
stimulating 17 28 78 89 I-chronic_disease
hormone 29 36 90 97 I-chronic_disease
( 37 38 98 99 I-chronic_disease
TSH 38 41 99 102 I-chronic_disease
) 41 42 102 103 I-chronic_disease

Body 0 4 104 108 B-bmi
mass 5 9 109 113 I-bmi
index 10 15 114 119 I-bmi
( 16 17 120 121 I-bmi
BMI)-for 17 25 121 129 I-bmi
- 25 26 129 130 O
age 26 29 130 133 B-age
percentile 30 40 134 144 O
< 41 42 145 146 O
5 43 44 147 148 B-upper_bound
% 44 45 148 149 I-upper_bound
( 46 47 150 151 O
underweight 47 58 151 162 O
) 58 59 162 163 O

DHEA 0 4 164 168 B-clinical_variable
- 4 5 168 169 I-clinical_variable
S 5 6 169 170 I-clinical_variable
elevation 7 16 171 180 I-clinical_variable
> 17 18 181 182 O
1.5 19 22 183 186 B-lower_bound
times 23 28 187 192 I-lower_bound
the 29 32 193 196 I-lower_bound
upper 33 38 197 202 I-lower_bound
reference 39 48 203 212 I-lower_bound
range 49 54 213 218 I-lower_bound
limit 55 60 219 224 I-lower_bound

Decreased 0 9 225 234 O
renal 10 15 235 240 O
function 16 24 241 249 O
evidenced 25 34 250 259 O
by 35 37 260 262 O
GFR 38 41 263 266 B-clinical_variable
< 42 43 267 268 O
60 44 46 269 271 B-upper_bound
ml 47 49 272 274 I-upper_bound
/ 49 50 274 275 I-upper_bound
min/1.73m2 50 60 275 285 I-upper_bound

Due 0 3 286 289 O
to 4 6 290 292 O
the 7 10 293 296 O
amount 11 17 297 303 O
of 18 20 304 306 O
blood 21 26 307 312 O
being 27 32 313 318 O
drawn 33 38 319 324 O
, 38 39 324 325 O
adolescent 40 50 326 336 O
volunteers 51 61 337 347 O
with 62 66 348 352 O
body 67 71 353 357 B-clinical_variable
weight 72 78 358 364 I-clinical_variable
< 79 80 365 366 O
25 81 83 367 369 B-upper_bound
kg 84 86 370 372 I-upper_bound

Early 0 5 373 378 O
morning 6 13 379 386 O
17 14 16 387 389 B-clinical_variable
- 16 17 389 390 I-clinical_variable
hydroxyprogesterone 17 36 390 409 I-clinical_variable
> 37 38 410 411 O
200 39 42 412 415 B-lower_bound
ng 43 45 416 418 I-lower_bound
/ 45 46 418 419 I-lower_bound
dl 46 48 419 421 I-lower_bound
measured 49 57 422 430 O
in 58 60 431 433 O
the 61 64 434 437 O
follicular 65 75 438 448 O
phase 76 81 449 454 O
, 81 82 454 455 O
which 83 88 456 461 O
suggests 89 97 462 470 O
the 98 101 471 474 O
possibility 102 113 475 486 O
of 114 116 487 489 O
congenital 117 127 490 500 B-chronic_disease
adrenal 128 135 501 508 I-chronic_disease
hyperplasia 136 147 509 520 I-chronic_disease
( 148 149 521 522 O
if 149 151 522 524 O
elevated 152 160 525 533 O
during 161 167 534 540 O
the 168 171 541 544 O
luteal 172 178 545 551 O
phase 179 184 552 557 O
, 184 185 557 558 O
the 186 189 559 562 O
17 190 192 563 565 O
- 192 193 565 566 O
hydroxyprogesterone 193 212 566 585 O
will 213 217 586 590 O
be 218 220 591 593 O
repeated 221 229 594 602 O
during 230 236 603 609 O
the 237 240 610 613 O
follicular 241 251 614 624 O
phase 252 257 625 630 O
) 257 258 630 631 O

Evidence 0 8 632 640 O
for 9 12 641 644 O
non 13 16 645 648 O
- 16 17 648 649 O
physiologic 17 28 649 660 O
or 29 31 661 663 O
non 32 35 664 667 B-chronic_disease
- 35 36 667 668 I-chronic_disease
PCOS 36 40 668 672 I-chronic_disease
causes 41 47 673 679 O
of 48 50 680 682 O
hyperandrogenism 51 67 683 699 B-treatment
and/or 68 74 700 706 O
anovulation 75 86 707 718 O

Evidence 0 8 719 727 O
of 9 11 728 730 O
virilization 12 24 731 743 B-chronic_disease
( 25 26 744 745 O
e.g. 26 30 745 749 O
, 30 31 749 750 O
rapidly 32 39 751 758 B-chronic_disease
progressive 40 51 759 770 I-chronic_disease
hirsutism 52 61 771 780 I-chronic_disease
, 61 62 780 781 O
deepening 63 72 782 791 B-chronic_disease
of 73 75 792 794 I-chronic_disease
the 76 79 795 798 I-chronic_disease
voice 80 85 799 804 I-chronic_disease
, 85 86 804 805 O
clitoromegaly 87 100 806 819 B-chronic_disease
) 100 101 819 820 O

For 0 3 821 824 O
girls 4 9 825 830 B-gender
with 10 14 831 835 O
hyperandrogenism 15 31 836 852 B-chronic_disease
: 31 32 852 853 O
serum 33 38 854 859 O
( 39 40 860 861 O
calculated 40 50 861 871 O
) 50 51 871 872 O
free 52 56 873 877 O
testosterone 57 69 878 890 O
concentration 70 83 891 904 O
greater 84 91 905 912 O
than 92 96 913 917 O
the 97 100 918 921 O
Tanner 101 107 922 928 O
stage 108 113 929 934 O
- 113 114 934 935 O
specific 114 122 935 943 O
reference 123 132 944 953 O
range 133 138 954 959 O
and/or 139 145 960 966 O
unequivocal 146 157 967 978 O
evidence 158 166 979 987 O
for 167 170 988 991 O
hirsutism 171 180 992 1001 B-chronic_disease

For 0 3 1002 1005 O
girls 4 9 1006 1011 B-gender
without 10 17 1012 1019 O
hyperandrogenism 18 34 1020 1036 B-chronic_disease
: 34 35 1036 1037 O
serum 36 41 1038 1043 O
( 42 43 1044 1045 O
calculated 43 53 1045 1055 O
) 53 54 1055 1056 O
free 55 59 1057 1061 O
testosterone 60 72 1062 1074 O
concentration 73 86 1075 1088 O
within 87 93 1089 1095 O
the 94 97 1096 1099 O
Tanner 98 104 1100 1106 O
stage 105 110 1107 1112 O
- 110 111 1112 1113 O
specific 111 119 1113 1121 O
reference 120 129 1122 1131 O
range 130 135 1132 1137 O
and 136 139 1138 1141 O
the 140 143 1142 1145 O
absence 144 151 1146 1153 O
of 152 154 1154 1156 O
hirsutism 155 164 1157 1166 O

General 0 7 1167 1174 O
good 8 12 1175 1179 O
health 13 19 1180 1186 O
( 20 21 1187 1188 O
excepting 21 30 1188 1197 O
overweight 31 41 1198 1208 B-chronic_disease
, 41 42 1208 1209 O
obesity 43 50 1210 1217 B-chronic_disease
, 50 51 1217 1218 O
hyperandrogenism 52 68 1219 1235 B-chronic_disease
, 68 69 1235 1236 O
and 70 73 1237 1240 O
adequately 74 84 1241 1251 O
- 84 85 1251 1252 O
treated 85 92 1252 1259 O
hypothyroidism 93 107 1260 1274 B-chronic_disease
) 107 108 1274 1275 O

Hematocrit 0 10 1276 1286 B-clinical_variable
< 11 12 1287 1288 O
36 13 15 1289 1291 B-upper_bound
% 15 16 1291 1292 I-upper_bound
and 17 20 1293 1296 O
hemoglobin 21 31 1297 1307 B-clinical_variable
< 32 33 1308 1309 O
12 34 36 1310 1312 B-upper_bound
g 37 38 1313 1314 I-upper_bound
/ 38 39 1314 1315 I-upper_bound
dl 39 41 1315 1317 I-upper_bound

History 0 7 1318 1325 O
and/or 8 14 1326 1332 O
physical 15 23 1333 1341 O
exam 24 28 1342 1346 O
findings 29 37 1347 1355 O
suggestive 38 48 1356 1366 O
of 49 51 1367 1369 O
Cushing 52 59 1370 1377 B-chronic_disease
's 59 61 1377 1379 I-chronic_disease
syndrome 62 70 1380 1388 I-chronic_disease
, 70 71 1388 1389 O
adrenal 72 79 1390 1397 B-chronic_disease
insufficiency 80 93 1398 1411 I-chronic_disease
, 93 94 1411 1412 O
or 95 97 1413 1415 O
acromegaly 98 108 1416 1426 B-chronic_disease

History 0 7 1427 1434 O
and/or 8 14 1435 1441 O
physical 15 23 1442 1450 O
exam 24 28 1451 1455 O
findings 29 37 1456 1464 O
suggestive 38 48 1465 1475 O
of 49 51 1476 1478 O
hypogonadotropic 52 68 1479 1495 B-chronic_disease
hypogonadism 69 81 1496 1508 I-chronic_disease
( 82 83 1509 1510 O
e.g. 83 87 1510 1514 O
, 87 88 1514 1515 O
symptoms 89 97 1516 1524 O
of 98 100 1525 1527 O
estrogen 101 109 1528 1536 B-chronic_disease
deficiency 110 120 1537 1547 I-chronic_disease
) 120 121 1547 1548 O
including 122 131 1549 1558 O
functional 132 142 1559 1569 O
hypothalamic 143 155 1570 1582 B-chronic_disease
amenorrhea 156 166 1583 1593 I-chronic_disease
( 167 168 1594 1595 O
which 168 173 1595 1600 O
may 174 177 1601 1604 O
be 178 180 1605 1607 O
suggested 181 190 1608 1617 O
by 191 193 1618 1620 O
a 194 195 1621 1622 O
constellation 196 209 1623 1636 O
of 210 212 1637 1639 O
symptoms 213 221 1640 1648 O
including 222 231 1649 1658 O
restrictive 232 243 1659 1670 O
eating 244 250 1671 1677 O
patterns 251 259 1678 1686 O
, 259 260 1686 1687 O
excessive 261 270 1688 1697 O
exercise 271 279 1698 1706 O
, 279 280 1706 1707 O
psychological 281 294 1708 1721 O
stress 295 301 1722 1728 O
, 301 302 1728 1729 O
etc 303 306 1730 1733 O
. 306 307 1733 1734 O
) 307 308 1734 1735 O

History 0 7 1736 1743 O
of 8 10 1744 1746 O
allergy 11 18 1747 1754 O
to 19 21 1755 1757 O
micronized 22 32 1758 1768 B-allergy_name
progesterone 33 45 1769 1781 I-allergy_name

Hyperprolactinemia 0 18 1782 1800 B-chronic_disease
: 18 19 1800 1801 O
Mild 20 24 1802 1806 O
prolactin 25 34 1807 1816 O
elevations 35 45 1817 1827 B-clinical_variable
may 46 49 1828 1831 O
be 50 52 1832 1834 O
seen 53 57 1835 1839 O
in 58 60 1840 1842 O
HA 61 63 1843 1845 B-chronic_disease
/ 63 64 1845 1846 O
PCOS 64 68 1846 1850 B-chronic_disease
, 68 69 1850 1851 O
and 70 73 1852 1855 O
elevations 74 84 1856 1866 O
within 85 91 1867 1873 O
20 92 94 1874 1876 B-lower_bound
% 94 95 1876 1877 I-lower_bound
higher 96 102 1878 1884 O
than 103 107 1885 1889 O
the 108 111 1890 1893 O
upper 112 117 1894 1899 O
limit 118 123 1900 1905 O
of 124 126 1906 1908 O
normal 127 133 1909 1915 O
will 134 138 1916 1920 O
be 139 141 1921 1923 O
accepted 142 150 1924 1932 O
in 151 153 1933 1935 O
this 154 158 1936 1940 O
group 159 164 1941 1946 O

Males 0 5 1947 1952 B-gender

Mid- 0 4 1953 1957 O
to 5 7 1958 1960 O
late 8 12 1961 1965 O
pubertal 13 21 1966 1974 O
adolescent 22 32 1975 1985 O
girl 33 37 1986 1990 B-gender
( 38 39 1991 1992 O
at 39 41 1992 1994 O
least 42 47 1995 2000 O
Tanner 48 54 2001 2007 B-clinical_variable
breast 55 61 2008 2014 I-clinical_variable
stage 62 67 2015 2020 I-clinical_variable
3 68 69 2021 2022 B-lower_bound
, 69 70 2022 2023 O
but 71 74 2024 2027 O
no 75 77 2028 2030 O
more 78 82 2031 2035 O
than 83 87 2036 2040 O
2 88 89 2041 2042 B-upper_bound
years 90 95 2043 2048 I-upper_bound
postmenarcheal 96 110 2049 2063 O
) 110 111 2063 2064 O

Mild 0 4 2065 2069 O
elevations 5 15 2070 2080 O
may 16 19 2081 2084 O
be 20 22 2085 2087 O
seen 23 27 2088 2092 O
in 28 30 2093 2095 O
adolescent 31 41 2096 2106 O
HA 42 44 2107 2109 B-chronic_disease
and 45 48 2110 2113 O
in 49 51 2114 2116 O
PCOS 52 56 2117 2121 B-chronic_disease
, 56 57 2121 2122 O
and 58 61 2123 2126 O
will 62 66 2127 2131 O
be 67 69 2132 2134 O
accepted 70 78 2135 2143 O
in 79 81 2144 2146 O
these 82 87 2147 2152 O
groups 88 94 2153 2159 O

No 0 2 2160 2162 O
medications 3 14 2163 2174 B-treatment
known 15 20 2175 2180 O
to 21 23 2181 2183 O
affect 24 30 2184 2190 O
the 31 34 2191 2194 O
reproductive 35 47 2195 2207 O
system 48 54 2208 2214 O
, 54 55 2214 2215 O
glucose 56 63 2216 2223 B-treatment
metabolism 64 74 2224 2234 I-treatment
, 74 75 2234 2235 O
lipid 76 81 2236 2241 B-treatment
metabolism 82 92 2242 2252 I-treatment
, 92 93 2252 2253 O
or 94 96 2254 2256 O
blood 97 102 2257 2262 O
pressure 103 111 2263 2271 O
can 112 115 2272 2275 O
be 116 118 2276 2278 O
taken 119 124 2279 2284 O
in 125 127 2285 2287 O
the 128 131 2288 2291 O
2 132 133 2292 2293 B-upper_bound
months 134 140 2294 2300 I-upper_bound
prior 141 146 2301 2306 I-upper_bound
to 147 149 2307 2309 O
the 150 153 2310 2313 O
screening 154 163 2314 2323 O
visit 164 169 2324 2329 O
and 170 173 2330 2333 O
in 174 176 2334 2336 O
the 177 180 2337 2340 O
3 181 182 2341 2342 B-upper_bound
months 183 189 2343 2349 I-upper_bound
prior 190 195 2350 2355 I-upper_bound
to 196 198 2356 2358 O
the 199 202 2359 2362 O
start 203 208 2363 2368 O
of 209 211 2369 2371 O
the 212 215 2372 2375 O
study 216 221 2376 2381 O
medications 222 233 2382 2393 O

Obesity 0 7 2394 2401 B-chronic_disease
resulting 8 17 2402 2411 O
from 18 22 2412 2416 O
a 23 24 2417 2418 O
well 25 29 2419 2423 O
- 29 30 2423 2424 O
defined 30 37 2424 2431 O
endocrinopathy 38 52 2432 2446 B-chronic_disease
or 53 55 2447 2449 O
genetic 56 63 2450 2457 B-chronic_disease
syndrome 64 72 2458 2466 I-chronic_disease

Persistent 0 10 2467 2477 O
liver 11 16 2478 2483 B-chronic_disease
panel 17 22 2484 2489 I-chronic_disease
abnormalities 23 36 2490 2503 I-chronic_disease

Positive 0 8 2504 2512 B-pregnancy
pregnancy 9 18 2513 2522 I-pregnancy
test 19 23 2523 2527 O

Previous 0 8 2528 2536 O
diagnosis 9 18 2537 2546 O
of 19 21 2547 2549 O
diabetes 22 30 2550 2558 B-chronic_disease
, 30 31 2558 2559 O
fasting 32 39 2560 2567 B-clinical_variable
glucose 40 47 2568 2575 I-clinical_variable
> 48 49 2576 2577 O
or 50 52 2578 2580 O
= 53 54 2581 2582 O
126 55 58 2583 2586 B-lower_bound
mg 59 61 2587 2589 I-lower_bound
/ 61 62 2589 2590 I-lower_bound
dl 62 64 2590 2592 I-lower_bound
, 64 65 2592 2593 O
or 66 68 2594 2596 O
a 69 70 2597 2598 O
hemoglobin 71 81 2599 2609 B-clinical_variable
A1c 82 85 2610 2613 I-clinical_variable
> 86 87 2614 2615 O
or 88 90 2616 2618 O
= 91 92 2619 2620 O
6.5 93 96 2621 2624 B-lower_bound
% 96 97 2624 2625 I-lower_bound

Restrictions 0 12 2626 2638 O
on 13 15 2639 2641 O
use 16 19 2642 2645 O
of 20 22 2646 2648 O
other 23 28 2649 2654 O
drugs 29 34 2655 2660 O
or 35 37 2661 2663 O
treatments 38 48 2664 2674 B-treatment

Severe 0 6 2675 2681 O
thrombocytopenia 7 23 2682 2698 B-chronic_disease
( 24 25 2699 2700 O
platelets 25 34 2700 2709 B-clinical_variable
< 35 36 2710 2711 O
50,000 37 43 2712 2718 B-upper_bound
cells 44 49 2719 2724 I-upper_bound
/ 49 50 2724 2725 I-upper_bound
microliter 50 60 2725 2735 I-upper_bound
) 60 61 2735 2736 O
or 62 64 2737 2739 O
leukopenia 65 75 2740 2750 B-chronic_disease
( 76 77 2751 2752 O
total 77 82 2752 2757 B-clinical_variable
white 83 88 2758 2763 I-clinical_variable
blood 89 94 2764 2769 I-clinical_variable
count 95 100 2770 2775 I-clinical_variable
< 101 102 2776 2777 O
4,000 103 108 2778 2783 B-upper_bound
cells 109 114 2784 2789 I-upper_bound
/ 114 115 2789 2790 I-upper_bound
microliter 115 125 2790 2800 I-upper_bound
) 125 126 2800 2801 O

Significant 0 11 2802 2813 O
history 12 19 2814 2821 O
of 20 22 2822 2824 O
cardiac 23 30 2825 2832 O
or 31 33 2833 2835 O
pulmonary 34 43 2836 2845 B-chronic_disease
dysfunction 44 55 2846 2857 I-chronic_disease
( 56 57 2858 2859 O
e.g. 57 61 2859 2863 O
, 61 62 2863 2864 O
known 63 68 2865 2870 O
or 69 71 2871 2873 O
suspected 72 81 2874 2883 O
congestive 82 92 2884 2894 B-chronic_disease
heart 93 98 2895 2900 I-chronic_disease
failure 99 106 2901 2908 I-chronic_disease
, 106 107 2908 2909 O
asthma 108 114 2910 2916 B-chronic_disease
requiring 115 124 2917 2926 O
intermittent 125 137 2927 2939 O
systemic 138 146 2940 2948 B-treatment
corticosteroids 147 162 2949 2964 I-treatment
, 162 163 2964 2965 O
etc 164 167 2966 2969 O
. 167 168 2969 2970 O
) 168 169 2970 2971 O

Total 0 5 2972 2977 O
testosterone 6 18 2978 2990 B-clinical_variable
> 19 20 2991 2992 O
150 21 24 2993 2996 B-lower_bound
ng 25 27 2997 2999 I-lower_bound
/ 27 28 2999 3000 I-lower_bound
dl 28 30 3000 3002 I-lower_bound
, 30 31 3002 3003 O
which 32 37 3004 3009 O
suggests 38 46 3010 3018 O
the 47 50 3019 3022 O
possibility 51 62 3023 3034 O
of 63 65 3035 3037 O
virilizing 66 76 3038 3048 B-cancer
ovarian 77 84 3049 3056 I-cancer
or 85 87 3057 3059 O
adrenal 88 95 3060 3067 B-cancer
tumor 96 101 3068 3073 I-cancer

Willing 0 7 3074 3081 O
to 8 10 3082 3084 O
strictly 11 19 3085 3093 O
avoid 20 25 3094 3099 O
pregnancy 26 35 3100 3109 B-pregnancy
with 36 40 3110 3114 O
use 41 44 3115 3118 O
of 45 47 3119 3121 O
reliable 48 56 3122 3130 O
non 57 60 3131 3134 O
- 60 61 3134 3135 O
hormonal 61 69 3135 3143 O
methods 70 77 3144 3151 O
during 78 84 3152 3158 O
the 85 88 3159 3162 O
study 89 94 3163 3168 O
period 95 101 3169 3175 O

adolescents 0 11 3176 3187 O
over 12 16 3188 3192 O
age 17 20 3193 3196 B-age
16 21 23 3197 3199 B-lower_bound
years 24 29 3200 3205 I-lower_bound

adolescents 0 11 3206 3217 O
under 12 17 3218 3223 O
age 18 21 3224 3227 B-age
16 22 24 3228 3230 B-upper_bound
years 25 30 3231 3236 I-upper_bound

